Skip to main content

Table 1 Characteristics of study population in the Women’s Health Initiative Observational Study

From: Anthropometric measures and serum estrogen metabolism in postmenopausal women: the Women’s Health Initiative Observational Study

Characteristic

Never or former menopausal hormone therapy users (n = 957)

Current menopausal hormone therapy users (n = 878)

n

%

Weighted %a

n

%

Weighted %a

Age at baseline blood draw

  <55 years

82

8.6

8.7

101

11.5

16.8

 55–59 years

177

18.5

17.3

194

22.1

25.8

 60–64 years

230

24.0

21.0

218

24.8

23.9

 65–69 years

201

21.0

23.1

178

20.3

18.3

 70–74 years

170

17.8

19.3

135

15.4

11.2

 75–79 years

97

10.1

10.6

52

5.9

4.0

Race

 White

841

87.9

89.4

825

94.0

93.5

Year at blood draw

 1993–1996

586

61.2

61.4

544

62.0

61.9

 1997–1998

371

38.8

38.6

334

38.0

38.1

Smoking status

 Never

488

51.0

50.2

427

48.6

45.9

 Former

402

42.0

41.3

416

47.4

48.8

 Current

67

7.0

8.5

35

4.0

5.3

Time since menopause

  <10 years

299

32.9

31.5

349

39.7

44.0

 10–19 years

359

39.5

38.7

330

37.6

34.8

 ≥ 20 years

250

27.5

29.9

199

22.7

21.1

Moderate- to vigorous-intensity physical activity

 0 MET-h/week

205

21.4

19.9

145

16.5

18.4

 0.1–9.9 MET-h/week

304

31.8

30.9

279

31.8

34.2

 ≥10.0 MET-h/week

448

46.8

49.3

454

51.7

47.4

Characteristic

n

Weighted n a

Weighted mean (SD)

n

Weighted n a

Weighted mean (SD)

Current BMI, kg/m2

953

30,814

27.0 (0.27)

877

25,152

26.6 (0.28)

BMI at age 18 years, kg/m2

933

30,149

20.6 (0.15)

859

24,661

20.5 (0.12)

Waist-to-hip ratio

952

30,720

0.81 (0.004)

877

25,152

0.79 (0.004)

Height, cm

956

30,817

162.2 (0.30)

877

25,152

163.1 (0.34)

  1. BMI Body mass index, MET Metabolic equivalent of task
  2. aWeighted percentages and weighted n reflect weighted counts and refer to the study cohort